Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL.

Rallidis LS, Kiouri E, Katsimardos A, Kotakos C.

Atherosclerosis. 2018 Aug;275:262-264. doi: 10.1016/j.atherosclerosis.2018.06.821. Epub 2018 Jun 18.

PMID:
29980053
2.

High levels of lipoprotein (a) and premature acute coronary syndrome.

Rallidis LS, Pavlakis G, Foscolou A, Kotakos C, Katsimardos A, Drosatos A, Zolindaki M, Panagiotakos DB.

Atherosclerosis. 2018 Feb;269:29-34. doi: 10.1016/j.atherosclerosis.2017.12.011. Epub 2017 Dec 7.

PMID:
29258004
3.

Eligibility for treatment with PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximum hypolipidaemic therapy.

Rallidis LS, Triantafyllis AS, Iliodromitis E.

Hellenic J Cardiol. 2017 Nov 8. pii: S1109-9666(17)30451-7. doi: 10.1016/j.hjc.2017.11.004. [Epub ahead of print] No abstract available.

4.

Need for more action when young hearts are broken.

Rallidis LS.

Pol Arch Intern Med. 2017 Oct 31;127(10):648-649. doi: 10.20452/pamw.4122. Epub 2017 Oct 24. No abstract available.

5.

Characteristics and Long-Term Prognosis of Patients ≤35 Years of Age with ST Segment Elevation Myocardial Infarction and "Normal or Near Normal" Coronary Arteries.

Rallidis LS, Gialeraki A, Triantafyllis AS, Tsirebolos G, Liakos G, Moutsatsou P, Iliodromitis E.

Am J Cardiol. 2017 Sep 1;120(5):740-746. doi: 10.1016/j.amjcard.2017.06.002. Epub 2017 Jun 13.

PMID:
28689750
6.

Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction.

Rallidis LS, Gialeraki A, Tsirebolos G, Tsalavoutas S, Rallidi M, Iliodromitis E.

J Thromb Thrombolysis. 2017 Aug;44(2):267-273. doi: 10.1007/s11239-017-1520-2.

PMID:
28647870
7.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.

Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Review.

PMID:
28521870
8.

Short-term effects of Mediterranean-type diet intervention on soluble cellular adhesion molecules in subjects with abdominal obesity.

Rallidis LS, Kolomvotsou A, Lekakis J, Farajian P, Vamvakou G, Dagres N, Zolindaki M, Efstathiou S, Anastasiou-Nana M, Zampelas A.

Clin Nutr ESPEN. 2017 Feb;17:38-43. doi: 10.1016/j.clnesp.2016.11.002. Epub 2016 Dec 23.

PMID:
28361746
9.

The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals.

Ehret GB, Ferreira T, Chasman DI, Jackson AU, Schmidt EM, Johnson T, Thorleifsson G, Luan J, Donnelly LA, Kanoni S, Petersen AK, Pihur V, Strawbridge RJ, Shungin D, Hughes MF, Meirelles O, Kaakinen M, Bouatia-Naji N, Kristiansson K, Shah S, Kleber ME, Guo X, Lyytikäinen LP, Fava C, Eriksson N, Nolte IM, Magnusson PK, Salfati EL, Rallidis LS, Theusch E, Smith AJP, Folkersen L, Witkowska K, Pers TH, Joehanes R, Kim SK, Lataniotis L, Jansen R, Johnson AD, Warren H, Kim YJ, Zhao W, Wu Y, Tayo BO, Bochud M; CHARGE-EchoGen consortium; CHARGE-HF consortium; Wellcome Trust Case Control Consortium, Absher D, Adair LS, Amin N, Arking DE, Axelsson T, Baldassarre D, Balkau B, Bandinelli S, Barnes MR, Barroso I, Bevan S, Bis JC, Bjornsdottir G, Boehnke M, Boerwinkle E, Bonnycastle LL, Boomsma DI, Bornstein SR, Brown MJ, Burnier M, Cabrera CP, Chambers JC, Chang IS, Cheng CY, Chines PS, Chung RH, Collins FS, Connell JM, Döring A, Dallongeville J, Danesh J, de Faire U, Delgado G, Dominiczak AF, Doney ASF, Drenos F, Edkins S, Eicher JD, Elosua R, Enroth S, Erdmann J, Eriksson P, Esko T, Evangelou E, Evans A, Fall T, Farrall M, Felix JF, Ferrières J, Ferrucci L, Fornage M, Forrester T, Franceschini N, Duran OHF, Franco-Cereceda A, Fraser RM, Ganesh SK, Gao H, Gertow K, Gianfagna F, Gigante B, Giulianini F, Goel A, Goodall AH, Goodarzi MO, Gorski M, Gräßler J, Groves C, Gudnason V, Gyllensten U, Hallmans G, Hartikainen AL, Hassinen M, Havulinna AS, Hayward C, Hercberg S, Herzig KH, Hicks AA, Hingorani AD, Hirschhorn JN, Hofman A, Holmen J, Holmen OL, Hottenga JJ, Howard P, Hsiung CA, Hunt SC, Ikram MA, Illig T, Iribarren C, Jensen RA, Kähönen M, Kang H, Kathiresan S, Keating BJ, Khaw KT, Kim YK, Kim E, Kivimaki M, Klopp N, Kolovou G, Komulainen P, Kooner JS, Kosova G, Krauss RM, Kuh D, Kutalik Z, Kuusisto J, Kvaløy K, Lakka TA, Lee NR, Lee IT, Lee WJ, Levy D, Li X, Liang KW, Lin H, Lin L, Lindström J, Lobbens S, Männistö S, Müller G, Müller-Nurasyid M, Mach F, Markus HS, Marouli E, McCarthy MI, McKenzie CA, Meneton P, Menni C, Metspalu A, Mijatovic V, Moilanen L, Montasser ME, Morris AD, Morrison AC, Mulas A, Nagaraja R, Narisu N, Nikus K, O'Donnell CJ, O'Reilly PF, Ong KK, Paccaud F, Palmer CD, Parsa A, Pedersen NL, Penninx BW, Perola M, Peters A, Poulter N, Pramstaller PP, Psaty BM, Quertermous T, Rao DC, Rasheed A, Rayner NWNWR, Renström F, Rettig R, Rice KM, Roberts R, Rose LM, Rossouw J, Samani NJ, Sanna S, Saramies J, Schunkert H, Sebert S, Sheu WH, Shin YA, Sim X, Smit JH, Smith AV, Sosa MX, Spector TD, Stančáková A, Stanton A, Stirrups KE, Stringham HM, Sundstrom J, Swift AJ, Syvänen AC, Tai ES, Tanaka T, Tarasov KV, Teumer A, Thorsteinsdottir U, Tobin MD, Tremoli E, Uitterlinden AG, Uusitupa M, Vaez A, Vaidya D, van Duijn CM, van Iperen EPA, Vasan RS, Verwoert GC, Virtamo J, Vitart V, Voight BF, Vollenweider P, Wagner A, Wain LV, Wareham NJ, Watkins H, Weder AB, Westra HJ, Wilks R, Wilsgaard T, Wilson JF, Wong TY, Yang TP, Yao J, Yengo L, Zhang W, Zhao JH, Zhu X, Bovet P, Cooper RS, Mohlke KL, Saleheen D, Lee JY, Elliott P, Gierman HJ, Willer CJ, Franke L, Hovingh GK, Taylor KD, Dedoussis G, Sever P, Wong A, Lind L, Assimes TL, Njølstad I, Schwarz PE, Langenberg C, Snieder H, Caulfield MJ, Melander O, Laakso M, Saltevo J, Rauramaa R, Tuomilehto J, Ingelsson E, Lehtimäki T, Hveem K, Palmas W, März W, Kumari M, Salomaa V, Chen YI, Rotter JI, Froguel P, Jarvelin MR, Lakatta EG, Kuulasmaa K, Franks PW, Hamsten A, Wichmann HE, Palmer CNA, Stefansson K, Ridker PM, Loos RJF, Chakravarti A, Deloukas P, Morris AP, Newton-Cheh C, Munroe PB.

Nat Genet. 2016 Oct;48(10):1171-1184. doi: 10.1038/ng.3667. Epub 2016 Sep 12.

10.

PCSK9 inhibition as an emerging lipid lowering therapy: Unanswered questions.

Rallidis LS, Lekakis J.

Hellenic J Cardiol. 2016 Mar-Apr;57(2):86-91. doi: 10.1016/j.hjc.2016.03.002. Epub 2016 Apr 11. Review.

11.

The fundamental importance of smoking cessation in those with premature ST-segment elevation acute myocardial infarction.

Rallidis LS, Pavlakis G.

Curr Opin Cardiol. 2016 Sep;31(5):531-6. doi: 10.1097/HCO.0000000000000320. Review.

PMID:
27428006
12.

A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study.

Alexopoulos D, Anastasiou-Nana M, Elisaf MS, Liberopoulos E, Rallidis LS, Davos CH, Moulis A, Nikas N, Zacharis E, Vardas P; CHALLENGE Investigators.

Int J Cardiol. 2016 Aug 15;217:183-9. doi: 10.1016/j.ijcard.2016.05.003. Epub 2016 May 3.

PMID:
27183455
13.

Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.

Rallidis LS, Triantafyllis AS, Tsirebolos G, Katsaras D, Rallidi M, Moutsatsou P, Lekakis J.

Atherosclerosis. 2016 Jun;249:17-21. doi: 10.1016/j.atherosclerosis.2016.03.023. Epub 2016 Mar 18.

PMID:
27062405
14.

Prevalence of metabolic syndrome and association with burden of atherosclerotic disease in patients with stable coronary artery disease.

Varounis C, Rallidis LS, Franco OH, Lekakis J.

Curr Med Res Opin. 2016 Jun;32(6):1175-81. doi: 10.1185/03007995.2016.1163257. Epub 2016 Apr 5.

PMID:
26950061
15.

Circadian aspects of myocardial infarction among young STEMI patients.

Rallidis LS, Triantafyllis AS, Varounis C, Rallidi M, Lekakis J.

Eur J Intern Med. 2016 Jan;27:e7-8. doi: 10.1016/j.ejim.2015.09.005. Epub 2015 Sep 26. No abstract available.

PMID:
26419581
16.

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.

Nikpay M, Goel A, Won HH, Hall LM, Willenborg C, Kanoni S, Saleheen D, Kyriakou T, Nelson CP, Hopewell JC, Webb TR, Zeng L, Dehghan A, Alver M, Armasu SM, Auro K, Bjonnes A, Chasman DI, Chen S, Ford I, Franceschini N, Gieger C, Grace C, Gustafsson S, Huang J, Hwang SJ, Kim YK, Kleber ME, Lau KW, Lu X, Lu Y, Lyytikäinen LP, Mihailov E, Morrison AC, Pervjakova N, Qu L, Rose LM, Salfati E, Saxena R, Scholz M, Smith AV, Tikkanen E, Uitterlinden A, Yang X, Zhang W, Zhao W, de Andrade M, de Vries PS, van Zuydam NR, Anand SS, Bertram L, Beutner F, Dedoussis G, Frossard P, Gauguier D, Goodall AH, Gottesman O, Haber M, Han BG, Huang J, Jalilzadeh S, Kessler T, König IR, Lannfelt L, Lieb W, Lind L, Lindgren CM, Lokki ML, Magnusson PK, Mallick NH, Mehra N, Meitinger T, Memon FU, Morris AP, Nieminen MS, Pedersen NL, Peters A, Rallidis LS, Rasheed A, Samuel M, Shah SH, Sinisalo J, Stirrups KE, Trompet S, Wang L, Zaman KS, Ardissino D, Boerwinkle E, Borecki IB, Bottinger EP, Buring JE, Chambers JC, Collins R, Cupples LA, Danesh J, Demuth I, Elosua R, Epstein SE, Esko T, Feitosa MF, Franco OH, Franzosi MG, Granger CB, Gu D, Gudnason V, Hall AS, Hamsten A, Harris TB, Hazen SL, Hengstenberg C, Hofman A, Ingelsson E, Iribarren C, Jukema JW, Karhunen PJ, Kim BJ, Kooner JS, Kullo IJ, Lehtimäki T, Loos RJF, Melander O, Metspalu A, März W, Palmer CN, Perola M, Quertermous T, Rader DJ, Ridker PM, Ripatti S, Roberts R, Salomaa V, Sanghera DK, Schwartz SM, Seedorf U, Stewart AF, Stott DJ, Thiery J, Zalloua PA, O'Donnell CJ, Reilly MP, Assimes TL, Thompson JR, Erdmann J, Clarke R, Watkins H, Kathiresan S, McPherson R, Deloukas P, Schunkert H, Samani NJ, Farrall M.

Nat Genet. 2015 Oct;47(10):1121-1130. doi: 10.1038/ng.3396. Epub 2015 Sep 7.

17.

Depressive symptomatology in patients with metabolic syndrome: A cross-sectional study of stable coronary artery disease patients.

Varounis C, Rallidis LS, Franco OH, Kotakos C, Lekakis J.

Eur J Intern Med. 2015 Nov;26(9):e54-5. doi: 10.1016/j.ejim.2015.07.020. Epub 2015 Aug 12. No abstract available.

PMID:
26277354
18.

Exclusive olive oil consumption has a protective effect on coronary artery disease; overview of the THISEAS study.

Dimitriou M, Rallidis LS, Theodoraki EV, Kalafati IP, Kolovou G, Dedoussis GV.

Public Health Nutr. 2016 Apr;19(6):1081-7. doi: 10.1017/S1368980015002244. Epub 2015 Jul 30.

PMID:
26223368
19.

Circadian pattern of symptoms onset in patients ≤35 years presenting with ST-segment elevation acute myocardial infarction.

Rallidis LS, Triantafyllis AS, Sakadakis EA, Gialeraki A, Varounis C, Rallidi M, Tsirebolos G, Liakos G, Dagres N, Lekakis J.

Eur J Intern Med. 2015 Oct;26(8):607-10. doi: 10.1016/j.ejim.2015.05.014. Epub 2015 Jun 12.

PMID:
26076942
20.

Real-Time 3-Dimensional Transesophageal Echocardiography: Its Incremental Value over 2-Dimensional Echocardiography in Assessing Acute Mitral Regurgitation.

Rallidis LS, Makavos G, Lozos V, Antoniadis A, Paraskevaidis I, Lekakis J.

Hellenic J Cardiol. 2015 May-Jun;56(3):260-1. No abstract available.

Supplemental Content

Loading ...
Support Center